KOPRAN LTD Valuation

KOPRAN · Healthcare · Current price ₹207.46

Full stock page
DocStoX fair value
₹128
low confidence
Current price
₹207
Upside
-38.5%
P/E ratio
38.9x
P/B ratio
1.7x
Verdict
Avoid
Model it yourself — Earnings Yield Calculator
Opens pre-filled with KOPRAN LTD's latest numbers.

Is KOPRAN LTD undervalued?

DocStoX estimates the fair value of KOPRAN LTD at ₹128 per share, versus the current market price of ₹207. That puts the stock about -38.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 3 independent methods: Residual income (₹101), Relative P/E (₹188), Graham floor (₹115). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹101 (bear) to ₹128 (base) to ₹188 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Valuation multiples

KOPRAN LTD trades at a P/E of 38.9x and a P/B of 1.7x, with a dividend yield of 1.7%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

Understand the ratios

P/E RatioP/B RatioPEG RatioEarnings Yield

More on KOPRAN LTD

Fair ValueIntrinsic ValueDCFFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.